Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HealthLynked Corp HLYK

HealthLynked Corp. is engaged in providing of healthcare technology solutions. It operates through three segments: the Health Services, the Digital Healthcare, and the Medical Distribution. The Health Services segment is comprised of the operations of Naples Womens Center (NWC), a medical group including (both obstetrics and gynecology) and general practice; Naples Center for Functional Medicine (NCFM), a functional medical practice engaged in improving the health of its patients through individualized and integrative health care; Bridging the Gap Physical Therapy (BTG), and Aesthetic Enhancements Unlimited (AEU). The Digital Healthcare segment develops and operates an online personal medical information and record archive system, the HealthLynked Network. The Medical Distribution segment is comprised of the operations of MedOffice Direct LLC (MOD), a virtual distributor of discounted medical supplies selling to both consumers and medical practices throughout the United States.


OTCQB:HLYK - Post by User

Post by averagepennieson Nov 15, 2023 9:40am
81 Views
Post# 35736538

HealthLynked Announces Q3 & Year-to-Date 2023 Financial Resu

HealthLynked Announces Q3 & Year-to-Date 2023 Financial Resu

2023 Year-to-Date Highlights

Revenue Increase: Achieved an 8% year-over-year (YoY) increase, totaling $4.796 million, compared to $4.45 million in the same period of 2022. Revenue growth was fueled by additional concierge fees and a steady increase in core technology subscription revenue.

Operational Efficiency: Operational loss was trimmed by a substantial 33%, declining from $4.51 million in 2022 to $3.04 million in 2023, due strategic restructuring resulting in a 13% reduction in operating expenses.

Strategic Divestiture Gains: A gain of $2.67 million was recognized related to the divestiture of ACO Health Partners in January 2023 and additional gains of $1.09 million were recognized related to collection of contingent sale consideration since the transaction. 

Net Income Achieved: Net income was $0.27 million, compared to net loss of $4.54 million in the same period of 2022, driven by the gains related to the sale of ACO Health Partners combined with year-over-year revenue and cost improvements.

 

https://www.prnewswire.com/news-releases/healthlynked-announces-q3--year-to-date-2023-financial-results-highlighted-by-8-revenue-growth-and-net-income-turnaround-301988219.html

<< Previous
Bullboard Posts
Next >>